Detalles de la búsqueda
1.
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Ann Rheum Dis
; 81(11): 1491-1503, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922124
2.
Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate.
Rheumatol Ther
; 10(2): 375-386, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36534208
3.
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis
; 29(1): 27-41, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342120
4.
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance.
Ther Adv Musculoskelet Dis
; 15: 1759720X231201047, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942277
5.
Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
J Pain Symptom Manage
; 42(6): 903-17, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21945130
Resultados
1 -
5
de 5
1
Próxima >
>>